- Home
- CRBU vs WOLF Comparison
CRBU vs WOLF Comparison
Compare CRBU & WOLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBU
- WOLF
- Stock Information
- Founded
- CRBU 2011
- WOLF 1987
- Country
- CRBU United States
- WOLF United States
- Employees
- CRBU N/A
- WOLF N/A
- Industry
- CRBU Medicinal Chemicals and Botanical Products
- WOLF Semiconductors
- Sector
- CRBU Health Care
- WOLF Technology
- Exchange
- CRBU Nasdaq
- WOLF Nasdaq
- Market Cap
- CRBU 188.8M
- WOLF 200.8M
- IPO Year
- CRBU 2021
- WOLF 1993
- Fundamental
- Price
- CRBU $1.90
- WOLF $1.39
- Analyst Decision
- CRBU Strong Buy
- WOLF Hold
- Analyst Count
- CRBU 4
- WOLF 13
- Target Price
- CRBU $8.50
- WOLF $10.21
- AVG Volume (30 Days)
- CRBU 1.8M
- WOLF 35.7M
- Earning Date
- CRBU 08-12-2025
- WOLF 08-20-2025
- Dividend Yield
- CRBU N/A
- WOLF N/A
- EPS Growth
- CRBU N/A
- WOLF N/A
- EPS
- CRBU N/A
- WOLF N/A
- Revenue
- CRBU $9,918,000.00
- WOLF $761,300,000.00
- Revenue This Year
- CRBU $9.52
- WOLF N/A
- Revenue Next Year
- CRBU N/A
- WOLF $14.42
- P/E Ratio
- CRBU N/A
- WOLF N/A
- Revenue Growth
- CRBU N/A
- WOLF N/A
- 52 Week Low
- CRBU $0.66
- WOLF $0.39
- 52 Week High
- CRBU $3.00
- WOLF $3.33
- Technical
- Relative Strength Index (RSI)
- CRBU 53.41
- WOLF 49.48
- Support Level
- CRBU $1.86
- WOLF $1.42
- Resistance Level
- CRBU $2.13
- WOLF $1.62
- Average True Range (ATR)
- CRBU 0.22
- WOLF 0.20
- MACD
- CRBU -0.05
- WOLF -0.00
- Stochastic Oscillator
- CRBU 15.76
- WOLF 17.91
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
About WOLF Wolfspeed Inc.
Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.